SastiMedic
Abmetop 25 price onlne

Abmetop 25 XL Tablet

MRP: ₹41.60

Packaging

TAB

Composition

Metoprolol 25mg

Company

Abbott India

Buy Now

Substitutes for Abmetop 25 XL Tablet

Medicine Company Price You Save
Embeta 25 mg Tablet 10s INTAS ₹16.28 Save ₹25.32
Cymet Er 25mg Tablet 10s Systopic ₹19.50 Save ₹22.10
Metapro 25 mg Tablet 10s Micro Labs ₹23.15 Save ₹18.45
Betabest XL 25 mg Tablet 10s Medley Pharma ₹30.00 Save ₹11.60
Actiblok-25 IPR Tab Biocon Ltd ₹31.50 Save ₹10.10
Metspot XL-25 Tab Cadila Pharma ₹31.58 Save ₹10.02
Lopresor 25mg Tablet 10s Novartis India ₹31.91 Save ₹9.69
Vasomet Xl 25mg Tablet 10s FDC ₹33.00 Save ₹8.60
Supermet XL 25 Tablet Abbott India ₹33.55 Save ₹8.05
Metolar-25mg Tab 10s Cipla ₹34.31 Save ₹7.29
Myoprol XL 25mg Tablet 10s Aristo Pharma ₹35.57 Save ₹6.03
Mettrust XL 25 Tablet 10s Centaur Labs ₹39.00 Save ₹2.60
Prolomet XL 25mg Tablet 10s Sun Pharma ₹39.12 Save ₹2.48
Cardibeta-XR-25 Tab Sun Pharma ₹40.95 Save ₹0.65
Metocard XL 25mg Tablet 10s Torrent Pharma ₹40.97 Save ₹0.63
Vinicor-XL 25 Tab 10s Ipca Labs ₹42.38
Revelol XL-25 Tab Ipca Labs ₹42.38
Metzok 25mg Tablet 10s USV ₹42.45
Metomac ER 25 Tab Macleods ₹43.00
Lopresor-XL 25mg Tablet 10s Novartis India ₹43.00
Tolol Xr 25 Tablet 10s Unichem ₹47.32
Betaone XL-25 Tab Dr. Reddy ₹47.32
Cardibeta-25 Tab Ranbaxy ₹52.49
Kingbeta-25 Tab 14s Panacea Biotec ₹62.00
Starpress XL 25mg Tablet 15s Lupin ₹63.55
Metox ER 25mg Tablet 14s Wockhardt ₹65.24
Metapro XL 25 mg Tablet 10s Micro Labs ₹67.42
Tec-Beta-25 Tab 15s Panacea Biotec ₹68.00
Metolar XR 25 mg Capsule 15s Cipla ₹69.00
Metpure XL-25 Tab Emcure Pharma ₹73.40
Betaloc-25mg Tab 30s Astra Zeneca ₹94.50
Starcad Beta 25mg Tablet 10s Lupin ₹105.55
Seloken XL 25mg Tablet 30s ASTRA ZENECA ₹117.30
Embeta XR 25 mg Tablet 10s INTAS ₹127.34

Uses of Abmetop 25 XL Tablet

Metoprolol, which is the generic form of Lopressor is not only used to treat hypertension.

Side Effects of Abmetop 25 XL Tablet

Dizziness, insomnia, tiredness, headache, vertigo, confusion, bradycardia, shortness of breath, hypotension, Raynaud's phenomenon, CHF, peripheral oedema, cold extremities, syncope, chest pain, palpitations, gangrene, claudication, hallucinations, nightmares, visual disturbances; diarrhoea, constipation, flatulence, GI pain, heartburn, nausea, hiccups, xerostomia; bronchoconstriction, wheezing, dyspnoea; dry skin, maculopapular, psoriasiform, pruritus, worsening of psoriasis, urticarial rash. Rarely, Peyronie's disease, tinnitus, restless legs, musculoskeletal pain, a polymyalgia-like syndrome, decreased libido, blurred vision, dry mucous membranes, sweating; reversible alopecia, thrombocytopenia, agranulocytosis, retroperitoneal fibrosis, wt gain, arthritis, dry eyes.

Drug Interactions

Additive effect w/ catecholamine-depleting drugs (e.g. reserpine) and MAOIs. May antagonise β1-adrenergic stimulating effects of sympathomimetics. Additive negative effects on SA or AV nodal conduction w/ cardiac glycosides, nondihydropyridine Ca channel blockers. Paradoxical response to epinephrine may occur. Increased plasma concentrations w/ CYP2D6 inhibitors (e.g. bupropion, cimetidine). Increased risk of hypotension and heart failure w/ myocardial depressant general anaesth (e.g. diethyl ether). Risk of pulmonary HTN w/ vasodilators (e.g. hydralazine) in uraemic patients. Reduced plasma levels w/ rifampicin. May increase negative inotropic and negative dromotropic effect of antiarrhythmic drugs (e.g. quinidine, amiodarone). May reduce antihypertensive efficacy w/ indometacin. May increase effects of hypoglycaemics.

Contraindications

2nd or 3rd degree AV block, sick sinus syndrome, hypotension, decompensated heart failure, sinus bradycardia, severe peripheral arterial circulatory disorders, cardiogenic shock, severe asthma and bronchospasm, untreated phaeochromocytoma, Prinzmetal's angina, metabolic acidosis.

Mechanism of Action

Metoprolol selectively inhibits β1-adrenergic receptors but has little or no effect on β2-receptors except in high doses. It does not exhibit membrane stabilising or intrinsic sympathomimetic activity. Onset: 1-2 hr (oral); 20 min, when infused over 10 min (IV). Duration: Oral: Approx 3-6 hr (immediate release); approx 24 hr (extended release). IV: 5-8 hr. Absorption: Absorbed readily and completely from the GI tract. Bioavailability increased by food. Bioavailability: Approx 50%. Time to peak plasma concentration: Approx 1.5-2 hr (oral). Distribution: Widely distributed, enters breast milk, crosses the placenta and blood-brain barrier. Volume of distribution: 3.2-5.6 L/kg. Plasma protein binding: Approx 12%. Metabolism: Extensively hepatic via CYP2D6 isoenzyme and undergoes oxidative deamination, O-dealkylation followed by oxidation and aliphatic hydroxylation. Excretion: Via urine (as metabolites and unchanged drug). Elimination half-life: 3-4 hr (fast hydroxylators); approx 7 hr (poor hydroxylators).

Special Precautions

Patients w/ myasthenia gravis, well-compensated heart failure, bronchospastic disease, AV conduction disorders, substantial cardiomegaly. May mask signs and symptoms of hyperthyroidism and hypoglycaemia. Patients w/ history of cardiac failure or those w/ minimal cardiac reserve. Patients undergoing major surgery involving general anaesth. Avoid abrupt withdrawal as it may precipitate thyroid storm or MI, and may exacerbate angina and ventricular arrhythmias. Hepatic impairment. Pregnancy and lactation. Patient Counselling May affect ability to drive or operate machinery. Monitoring Parameters Monitor BP, ECG and heart rate.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by Abbott India

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist